SCHEMBL6808065

SCHEMBL6808065

C=CCN1CCCc2cc(C(=O)OC)ccc21

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK1 Q15118 1/20 0.51
PDK2 Q15119 1/20 0.51
PDK3 Q15120 1/20 0.51
PDK4 Q16654 1/20 0.51
SRD5A1 P18405 3/20 0.46
SRD5A2 P31213 3/20 0.46
HDAC1 Q13547 9/20 0.45
HDAC6 Q9UBN7 9/20 0.45
HDAC8 Q9BY41 6/20 0.45
HDAC3 O15379 2/20 0.45
HDAC4 P56524 2/20 0.45
HDAC7 Q8WUI4 2/20 0.45
HDAC2 Q92769 2/20 0.45
HDAC11 Q96DB2 2/20 0.45
HDAC9 Q9UKV0 2/20 0.45
HDAC5 Q9UQL6 2/20 0.45
CYP2C19 P33261 1/20 0.45
KDM4E B2RXH2 2/20 0.44
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6811829 0.87 HDAC1 (0.42) PDK1PDK2PDK3PDK4SRD5A1
SCHEMBL6816345 0.86 ALDH1A1 (0.47) PDK1PDK2PDK3PDK4HDAC1
SCHEMBL6812162 0.85 HDAC1 (0.47) HDAC1HDAC6HDAC8HDAC3HDAC4
SCHEMBL6811518 0.84 HDAC1 (0.59) HDAC1HDAC6HDAC8HDAC3HDAC4
SCHEMBL2759073 0.82 TP53 (0.58) PDK1PDK2PDK3PDK4SRD5A1
SCHEMBL6808719 0.80 HDAC1 (0.45) HDAC1HDAC6HDAC8HDAC3HDAC4
SCHEMBL847263 0.80 PDK1 (0.50) PDK1PDK2PDK3PDK4SRD5A1
SCHEMBL31476414 0.80 HDAC1 (0.57) HDAC1HDAC6HDAC8HDAC3HDAC4
SCHEMBL19889063 0.79 PDK1 (0.60) PDK1PDK2PDK3PDK4SRD5A1
SCHEMBL10816704 0.78 HSD17B10 (0.51) PDK1PDK2PDK3PDK4HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040122001-A1 Pharmaceutical compounds ELI LILLY AND COMPANY 2004-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040122001-A1 Pharmaceutical compounds CYP2D6, LPXN, CYP1B1 PDK1 2940/4885PDK2 3608/4885PDK3 3224/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.